Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber
Organto announces second quarter results

'Largest profit quarter in the history of Organto'

Organto Foods Inc. announced financial results for the second quarter ended June 30, 2020. All amounts are expressed in Canadian dollars and results are reported in accordance with International Financial Reporting Standards (IFRS), except where specifically noted.

Highlights:
Second quarter revenues of $2,163,955, an increase of approximately 3,350% versus the same quarter in the prior year. Second quarter revenues represent the largest quarterly revenues in the history of Organto.

Year-to-date revenues of $3,773,775, an increase of approximately 1,850% versus the same period in the prior year. Revenues for the first six months of fiscal 2020 exceed revenues for the full twelve months of fiscal 2019.

Gross profit of $232,504 or 10.7% of revenues, an increase of approximately 2,700% versus the same quarter in the prior year, and the largest quarterly gross profit in the history of Organto.

YTD gross profit of $392,981 or 10.4% of revenues, versus negative gross profits of ($22,866) for the same period in the prior year.

Overhead costs in the second quarter, including certain costs related to financing completed during the quarter, reduced to 29.8% of revenues versus 36.4% in the first quarter of 2020 and over 100% in the prior year.

Balance sheet strengthened with cash position of $1,577,017 and working capital deficit improved versus Q-1 2020 by $3,131,759.

"Our second quarter results represent our fourth consecutive quarter of record revenues and the largest revenue and gross profit quarter in our history. We are pleased with our progress, and when combined with our recently completed oversubscribed financings, we believe we are well positioned for exciting growth." commented Steve Bromley, Chair and Interim CEO of Organto.

"Demand for fresh organic fruits and vegetables continues to grow, driven by increased consumer interest in healthy foods that are produced in a sustainable and transparent manner. We believe our cost-effective and flexible business model has proven its value and that we are well positioned to benefit from market demand. The funds raised from our recently closed financings will be used to expand our supply and range of product offerings and accelerate our growth, enabling our business to ramp up to an annualized revenue run rate of CDN $20 million and achieving cash-flow breakeven by year-end, both key milestones in our strategic plan."

Second Quarter Results
Revenues for the second quarter were a record $2,163,955, an increase of approximately 3,350% versus the same quarter in the prior year. Second quarter revenues were the largest quarterly revenues in the Company's history, driven sales of organic and non-GMO avocado, asparagus, ginger and a range of soft fruits.

Gross profit was $232,504 or 10.7% of revenues, also a record and the largest quarterly gross profit in the Company's history, versus gross profit of $8,265 in the prior year.

Selling, general and administrative expenses in the quarter were $188,822 versus $229,231 in the prior year, a decrease of 17.7%, due to primarily to streamlined administration processes and reduced professional fees. Included in current quarter costs are approximately $25,000 related to the convertible note and equity financings which were completed during the quarter. Management fees in the quarter were $158,441 versus $159,058 in the prior year, while salaries and benefits in the quarter were $232,013 versus $109,208 in the prior year. The increase in salaries and benefits was as expected, driven by incremental commercial and administrative resources required to both support growth realized to date and position the business for continued future growth. Non-cash stock-based compensation was $65,21 in the quarter versus $67,526 in the prior year.

Loss from continuing operations in the second quarter was $355,724 or $0.00 per common share versus a loss of $556,381 or $0.00 per common share in the prior year. Net loss for the second quarter was $355,724 versus net income of $743,974 in the prior year. During the second quarter of 2019 the Company realized a gain from discontinued operations of $1,300,355 representing the sale of the Company's medicinal cannabis operations.

At June 30, 2020, Organto's balance sheet reflected total assets of $4,468,718 including cash of $1,577,017. Included in liabilities is short-term loans payable of $704,946 and non-current debt of $2,007,500.

Extension of Bridge Loans
On April 28, 2020 the Company announced that it had reached an agreement with a former executive and director (the "Bridge Lender") of the Company to extend certain bridge loans originally made in 2018, and to grant 1.5 million warrants to the Bridge Lender at a strike price of C$0.065 per share for a period of 18 months subject to TSX regulations. The Company has received TSX Venture Exchange acceptance and the warrants have been issued. As per TSX Venture Exchange policy 5.1, the expiry date for a pro-rata portion of the warrants will be accelerated for any loan payments made between May 2020 and May 2021.

For more information:
Organto
Tel: 604-634-0970
Tel: 1-888-818-1364
Email: info@organto.com 
www.organto.com 

Publication date: